SEC Form 3 filed by new insider Stephenson Brian C
3 - Faeth Therapeutics, Inc. (0001829802) (Issuer)
Live Feed
Delayed 3mPress · Analyst · Insider · Buys · SEC · FDA
Signed out · 3-min delay · Sign up for real-time
- ProAssurance Corporation filed SEC Form 8-K: Other Events
8-K - PROASSURANCE CORP (0001127703) (Filer)
- SEC Form 4 filed by Director Graham G. Walmsley
4 - Olema Pharmaceuticals, Inc. (0001750284) (Issuer)
- Director Owen Adams Catherine converted options into 2,816 shares, increasing direct ownership by 35% to 10,865 units (SEC Form 4)
4 - AGIOS PHARMACEUTICALS, INC. (0001439222) (Issuer)
- FiEE Inc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
8-K - FiEE, Inc. (0001467761) (Filer)
- SEC Form 144 filed by ServiceTitan Inc.
144 - ServiceTitan, Inc. (0001638826) (Subject)
- SEC Form S-8 filed by Nexstar Media Group Inc.
S-8 - NEXSTAR MEDIA GROUP, INC. (0001142417) (Filer)
- Director Scadden David converted options into 2,816 shares, increasing direct ownership by 16% to 20,419 units (SEC Form 4)
4 - AGIOS PHARMACEUTICALS, INC. (0001439222) (Issuer)
- United Parks & Resorts Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
8-K - United Parks & Resorts Inc. (0001564902) (Filer)
- Director Iglesias Sanchez Oscar sold $143,260 worth of Ordinary Shares (14,276 units at $10.04), decreasing direct ownership by 12% to 104,111 units (SEC Form 4)
4 - Codere Online Luxembourg, S.A. (0001866782) (Issuer)
- SEC Form 6-K filed by Freight Technologies Inc.
6-K - Freight Technologies, Inc. (0001687542) (Filer)
- Core & Main Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
8-K - Core & Main, Inc. (0001856525) (Filer)
- SEC Form 4 filed by EVP Greiff Andrew S
4 - Ryerson Holding Corp (0001481582) (Issuer)
- SEC Form 11-K filed by SEI Investments Company
11-K - SEI INVESTMENTS CO (0000350894) (Filer)
- SEC Form 8-K filed by Tango Therapeutics Inc.
8-K - Tango Therapeutics, Inc. (0001819133) (Filer)
- Director Smith Cynthia converted options into 2,816 shares, increasing direct ownership by 23% to 15,230 units (SEC Form 4)
4 - AGIOS PHARMACEUTICALS, INC. (0001439222) (Issuer)
- SEC Form 4 filed by Executive Vice President & CFO Claussen James J
4 - Ryerson Holding Corp (0001481582) (Issuer)